A citation-based method for searching scientific literature

Luis Felipe Sallum, Liliana Andrade, Larissa Bastos Eloy da Costa, Susana Ramalho, Amanda Canato Ferracini, Rodrigo de Andrade Natal, Angelo Borsarelli Carvalho Brito, Luis Otávio Sarian, Sophie Derchain. Int J Gynecol Cancer 2018
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
50

Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers.
Francesco Raspagliesi, Giorgio Bogani, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Chiara Borghi, Cono Scaffa, Federica Morano, Giuseppa Maltese, Domenica Lorusso. Ann Surg Oncol 2017
8
25

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.
Koji Matsuo, Kwong-Kwok Wong, Christina Fotopoulou, Erin A Blake, Sharon E Robertson, Tanja Pejovic, Marina Frimer, Vishakha Pardeshi, Wei Hu, Jong-Sun Choi,[...]. J Surg Oncol 2018
7
25


Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.
David M Gershenson, Diane C Bodurka, Robert L Coleman, Karen H Lu, Anais Malpica, Charlotte C Sun. J Clin Oncol 2017
94
25

Low-grade serous ovarian cancer: A review.
Anis Kaldawy, Yakir Segev, Ofer Lavie, Ron Auslender, Victoria Sopik, Steven A Narod. Gynecol Oncol 2016
78
25

Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer.
Diogo Torres, Amanika Kumar, Sumer K Wallace, Jamie N Bakkum-Gamez, Gottfried E Konecny, Amy L Weaver, Michaela E McGree, Ellen L Goode, William A Cliby, Chen Wang. Gynecol Oncol 2017
21
25

Hormone receptor expression profile of low-grade serous ovarian cancers.
Marianna Buttarelli, Floriana Mascilini, Gian Franco Zannoni, Alessandra Ciucci, Enrica Martinelli, Flavia Filippetti, Giovanni Scambia, Gabriella Ferrandina, Daniela Gallo. Gynecol Oncol 2017
16
25


Survival in women with grade 1 serous ovarian carcinoma.
Amanda Nickles Fader, James Java, Stefanie Ueda, Robert E Bristow, Deborah K Armstrong, Michael A Bookman, David M Gershenson. Obstet Gynecol 2013
49
25

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses.
Giorgio Bogani, Elena Tagliabue, Mauro Signorelli, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Ilaria Sabatucci, Umberto Leone Roberti Maggiore, Domenica Lorusso,[...]. J Gynecol Oncol 2018
10
25



Impact of comorbidity index on survival in endometrial cancer.
Giorgio Bogani, Stefano Uccella, Fabio Ghezzi. Am J Clin Oncol 2014
6
25

Long-term safety of fertility sparing surgery in early stage ovarian cancer: comparison to standard radical surgical procedures.
Antonino Ditto, Fabio Martinelli, Giorgio Bogani, Domenica Lorusso, Marialuisa Carcangiu, Valentina Chiappa, Claudio Reato, Cristina Donfrancesco, Karla Jeanette Amaya De Carrillo, Francesco Raspagliesi. Gynecol Oncol 2015
41
25

Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase.
Jacek P Grabowski, Philipp Harter, Florian Heitz, Eric Pujade-Lauraine, Alexander Reuss, Gunnar Kristensen, Isabelle Ray-Coquard, Julia Heitz, Alexander Traut, Jacobus Pfisterer,[...]. Gynecol Oncol 2016
77
25

The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study.
Giorgio Bogani, Laura Matteucci, Stefano Tamberi, Valentina Arcangeli, Antonino Ditto, Giuseppa Maltese, Mauro Signorelli, Fabio Martinelli, Valentina Chiappa, Umberto Leone Roberti Maggiore,[...]. Int J Gynecol Cancer 2017
12
25

The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer.
Erin K Crane, Charlotte C Sun, Pedro T Ramirez, Kathleen M Schmeler, Anais Malpica, David M Gershenson. Gynecol Oncol 2015
29
25

[LOW GRADE OVARIAN CANCER].
Yakir Segev, Anis Kaldawy, Ron Auslender, Ofer Lavie. Harefuah 2017
1
100

Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
Amanda N Fader, Jennifer Bergstrom, Amelia Jernigan, Edward J Tanner, Kara Long Roche, Rebecca L Stone, Kimberly L Levinson, Stephanie Ricci, Stephanie Wethingon, Tian-Li Wang,[...]. Gynecol Oncol 2017
36
25

Trends of low-grade serous ovarian carcinoma in the United States.
Koji Matsuo, Hiroko Machida, Brendan H Grubbs, Anil K Sood, David M Gershenson. J Gynecol Oncol 2018
17
25

Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer.
Allison Gockley, Alexander Melamed, Amy J Bregar, Joel T Clemmer, Michael Birrer, John O Schorge, Marcela G Del Carmen, J Alejandro Rauh-Hain. Obstet Gynecol 2017
52
25

BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study.
M Thrall, H H Gallion, R Kryscio, M Kapali, D K Armstrong, Julie A DeLoia. Int J Gynecol Cancer 2006
61
25

Risk prediction model for epithelial ovarian cancer using molecular markers and clinical characteristics.
Meiying Zhang, Guanglei Zhuang, Xiangjun Sun, Yanying Shen, Aimin Zhao, Wen Di. J Ovarian Res 2015
9
25

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
25

Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.
Mengjiao Li, Haoran Li, Fei Liu, Rui Bi, Xiaoyu Tu, Lihua Chen, Shuang Ye, Xi Cheng. J Ovarian Res 2017
29
25


Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
25

The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection.
Mette Hjortkjær, Marianne Waldstrøm, Anders Jakobsen, Hanne Kanstrup, Erik Søgaard-Andersen, Karina Dahl Steffensen. Int J Gynecol Pathol 2017
18
25

BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer.
M Moschetta, A George, S B Kaye, S Banerjee. Ann Oncol 2016
95
25

A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma.
Chao-Yang Sun, Tie-Fen Su, Na Li, Bo Zhou, En-Song Guo, Zong-Yuan Yang, Jing Liao, Dong Ding, Qin Xu, Hao Lu,[...]. Oncotarget 2016
5
25



Biomarkers for Homologous Recombination Deficiency in Cancer.
Michal M Hoppe, Raghav Sundar, David S P Tan, Anand D Jeyasekharan. J Natl Cancer Inst 2018
94
25

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
25

Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.
Roland F Schwarz, Charlotte K Y Ng, Susanna L Cooke, Scott Newman, Jillian Temple, Anna M Piskorz, Davina Gale, Karen Sayal, Muhammed Murtaza, Peter J Baldwin,[...]. PLoS Med 2015
197
25

Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.
Larissa A Meyer, Weiguo He, Charlotte C Sun, Hui Zhao, Alexi A Wright, Rudy S Suidan, Joseph Dottino, J Alejandro Rauh-Hain, Karen H Lu, Sharon H Giordano. Gynecol Oncol 2018
21
25

Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma.
Brian D McMillen, Margarita M Aponte, Zhaojian Liu, Irene B Helenowski, Denise M Scholtens, Barbara M Buttin, Jian-Jun Wei. Mod Pathol 2012
33
25

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.
Francisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, Julie M Cunningham, Brooke L Fridley, Melissa C Larson, Kathryn Alsop, Ed Dicks, Patricia Harrington, Susan J Ramus,[...]. Clin Cancer Res 2015
94
25


Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
Michael Friedlander, Ursula Matulonis, Charlie Gourley, Andreas du Bois, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Br J Cancer 2018
71
25



Loss of BRCA1 protein expression as indicator of the BRCAness phenotype is associated with favorable overall survival after complete resection of sporadic ovarian cancer.
Marc P Radosa, Norman Häfner, Oumar Camara, Herbert Diebolder, Anke Mothes, Harald Winzer, Lars Jansen, Matthias Dürst, Ingo B Runnebaum. Int J Gynecol Cancer 2011
16
25

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
371
25

Prevalence of BRCA1 expression in epithelial ovarian cancer: immunohistochemical study.
Nakarin Sirisabya, Tarinee Manchana, Wichai Termrungreunglert, Surang Triratanachat, Navapun Charuruks, Damrong Tresukosol. J Med Assoc Thai 2007
8
25

Ovarian cancer.
Ursula A Matulonis, Anil K Sood, Lesley Fallowfield, Brooke E Howitt, Jalid Sehouli, Beth Y Karlan. Nat Rev Dis Primers 2016
331
25

Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.
Shazia Akbar, Lee B Jordan, Colin A Purdie, Alastair M Thompson, Stephen J McKenna. Br J Cancer 2015
17
25

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.
Elizabeth M Swisher, Rachel M Gonzalez, Toshiyasu Taniguchi, Rochelle L Garcia, Tom Walsh, Barbara A Goff, Piri Welcsh. Mol Cancer 2009
73
25

Practical methods for incorporating summary time-to-event data into meta-analysis.
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, Sarah Burdett, Matthew R Sydes. Trials 2007
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.